Rybczynska Anna A, Elsinga Philip H, Sijbesma Jurgen W, Ishiwata Kiichi, de Jong Johan R, de Vries Erik F, Dierckx Rudi A, van Waarde Aren
Nuclear Medicine and Molecular Imaging, University of Groningen Medical Center, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.
Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1167-75. doi: 10.1007/s00259-009-1076-2. Epub 2009 Feb 27.
Sigma receptors are implicated in memory and cognitive functions, drug addiction, depression and schizophrenia. In addition, sigma receptors are strongly overexpressed in many tumours. Although the natural ligands are still unknown, steroid hormones are potential candidates. Here, we examined changes in binding of the sigma-1 agonist (11)C-SA4503 in C6 glioma cells and in living rats after modification of endogenous steroid levels.
(11)C-SA4503 binding was assessed in C6 monolayers by gamma counting and in anaesthetized rats by microPET scanning. C6 cells were either repeatedly washed and incubated in steroid-free medium or exposed to five kinds of exogenous steroids (1 h or 5 min before tracer addition, respectively). Tumour-bearing male rats were repeatedly treated with pentobarbital (a condition known to result in reduction of endogenous steroid levels) or injected with progesterone.
Binding of (11)C-SA4503 to C6 cells was increased (approximately 50%) upon removal and decreased (approximately 60%) upon addition of steroid hormones (rank order of potency: progesterone > allopregnanolone = testosterone = androstanolone > dehydroepiandrosterone-3-sulphate, IC(50) progesterone 33 nM). Intraperitoneally administered progesterone reduced tumour uptake and tumour-to-muscle contrast (36%). Repeated treatment of animals with pentobarbital increased the PET standardized uptake value of (11)C-SA4503 in tumour (16%) and brain (27%), whereas the kinetics of blood pool radioactivity was unaffected.
The binding of (11)C-SA4503 is sensitive to steroid competition. Since not only increases but also decreases of steroid levels affect ligand binding, a considerable fraction of the sigma-1 receptor population in cultured tumour cells or tumour-bearing animals is normally occupied by endogenous steroids.
西格玛受体与记忆和认知功能、药物成瘾、抑郁症及精神分裂症有关。此外,西格玛受体在许多肿瘤中强烈过表达。尽管其天然配体仍不清楚,但甾体激素是潜在候选者。在此,我们检测了内源性甾体水平改变后,西格玛-1激动剂(11)C-SA4503在C6胶质瘤细胞和活体大鼠中的结合变化。
通过γ计数评估(11)C-SA4503在C6单层细胞中的结合情况,并通过微型PET扫描评估在麻醉大鼠中的结合情况。C6细胞要么反复洗涤并在无甾体培养基中孵育,要么分别在加入示踪剂前1小时或5分钟暴露于五种外源性甾体。荷瘤雄性大鼠反复用戊巴比妥治疗(已知该条件会导致内源性甾体水平降低)或注射孕酮。
去除甾体激素后,(11)C-SA4503与C6细胞的结合增加(约50%),添加甾体激素后结合减少(约60%)(效力排序:孕酮>别孕烯醇酮=睾酮=雄诺龙>硫酸脱氢表雄酮,孕酮的IC50为33 nM)。腹腔注射孕酮降低了肿瘤摄取和肿瘤与肌肉的对比度(36%)。用戊巴比妥反复治疗动物会增加肿瘤(16%)和脑(27%)中(11)C-SA4503的PET标准化摄取值,而血池放射性动力学不受影响。
(11)C-SA4503的结合对甾体竞争敏感。由于甾体水平的升高和降低都会影响配体结合,因此培养的肿瘤细胞或荷瘤动物中相当一部分西格玛-1受体通常被内源性甾体占据。